STK11 and neoplasm: As respiratory chain complex I is a target of Met (4, 5), the inhibition of oxidative phosphorylation (OxPhos) followed by the activation of liver kinase B1 (LKB1)/AMP-activated protein kinase (AMPK) axis may downregulate mTORC1 in tumor cells (6–8).